ArticleJournal of neuro-oncology2012
Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
Article in Journal of neuro-oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Gemcitabine-induced myositis in a patient with pancreatic cancer.BMJ case reports · 2025Review
- Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature.World journal of clinical cases · 2023Article
- Gemcitabine-Induced Myositis in a Luminal B Breast Cancer patient: A Case Report.Clinical medicine insights. Case reports · 2023Article
- Gemcitabine-induced myositis in a diabetes mellitus patient on hemodialysis.The Korean journal of internal medicine · 2017Article
- Chemotherapy-Related Neurotoxicity.Current neurology and neuroscience reports · 2016Review
- Cancer-treatment-induced neurotoxicity--focus on newer treatments.Nature reviews. Clinical oncology · 2016Review
- Gemcitabine-induced radiation recall myositis.Skeletal radiology · 2015Review
- Gemcitabine-induced radiation recall myositis in a patient with relapsed nasopharyngeal carcinoma.Practical radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Gemcitabine potential myotoxicity has been described in several cases of radiation recall and in patients treated with gemcitabine alone or in combination with other chemotherapy agents. We report two cases of gemcitabine related myositis identified at our institution, and perform a literature review of cases which meet the criteria for gemcitabine induced myositis associated to either radiation therapy or chemotherapy alone.
Indexed as
Identifiers
21811892What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.